Literature DB >> 4745852

Evaluation of carcinoembryonic antigen in human mammary carcinoma.

T M Chu, T Nemoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4745852     DOI： 10.1093/jnci/51.4.1119

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

1.  Secretion of immunoreactive calcitonin by human breast carcinomas.

Authors:  R C Coombes; G C Easty; S I Detre; C J Hillyard; U Stevens; S I Girgis; L S Galante; L Heywood; I Macintyre; A M Neville
Journal:  Br Med J       Date:  1975-10-25

2.  The clinical value of tissue carcinoembryonic antigen in breast cancer.

Authors:  S Haga; O Watanabe; T Shimizu; H Imamura; T Iida; M Makita; T Kajiwara
Journal:  Jpn J Surg       Date:  1991-05

3.  Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer.

Authors:  H Sonoo; J Kurebayashi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Carcino-embryonic antigen assay as a guide to tumour bulk, response to therapy and prognosis in human breast cancer.

Authors:  B Cantwell; M J Duffy; J J Fennelly; M Jones; G Duffy; L Daly
Journal:  Ir J Med Sci       Date:  1980-12       Impact factor: 1.568

Review 5.  Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncology.

Authors:  A M Neville; A M Mackay; J Westwood; C Turberville; D J Laurence
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

6.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

Review 7.  Carcinoembryonic antigen in patients with breast or colon cancer.

Authors:  Y N Lee
Journal:  West J Med       Date:  1978-11

8.  The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.

Authors:  D E Haagensen; W F Barry; T A McCook; J Giannola; S Ammirata; S A Wells
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

9.  Prospective assessment of the role of five tumour markers in breast cancer.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; J Pearson; R W Blamey; A Howell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer.

Authors:  T Okino; N Kan; M Nakanishi; K Satoh; K Mise; Y Teramura; S Yamasaki; T Hori; H Kodama; K Ohgaki
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.